Home › Funds › Roundhill GLP-1 & Weight Loss ETF
Fund family: Roundhill ETF Trust · Filed by Roundhill ETF Trust (CIK 1976517) · SEC series S000085000
Ticker: OZEM (C000249863)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 243 with, 7 against, 8 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 6 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Roundhill ETF Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 136 | 0 |
| Capital Structure | 24 | 0 |
| Audit-related | 20 | 0 |
| Corporate Governance | 20 | 4 |
| Say-on-Pay | 15 | 0 |
| Compensation | 14 | 0 |
| Other | 13 | 0 |
| Extraordinary Transactions | 12 | 0 |
| Human Rights or Human Capital/workforce | 2 | 2 |
| Other Social Issues | 2 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| ELI LILLY AND COMPANY | May 4, 2026 | $12M | 10 | 2 |
| PFIZER INC. | April 23, 2026 | $3M | 16 | 1 |
| REGENERON PHARMACEUTICALS, INC. | June 12, 2026 | $2M | 7 | 0 |
| AMGEN INC. | May 19, 2026 | $2M | 15 | 1 |
| MBX BIOSCIENCES | June 4, 2026 | $2M | 3 | 0 |
| GILEAD SCIENCES, INC. | April 30, 2026 | $1M | 15 | 3 |
| RHYTHM PHARMACEUTICALS, INC. | June 24, 2026 | $909,603 | 4 | 0 |
| VIKING THERAPEUTICS INC | May 19, 2026 | $556,395 | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| April 23, 2026 | PFIZER INC. | Adopt an Independent Chair Policy Shareholder proposal | Against | For |
| May 19, 2026 | AMGEN INC. | Stockholder proposal to require an independent board chairman. Shareholder proposal | Against | For |
| April 30, 2026 | GILEAD SCIENCES, INC. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | GILEAD SCIENCES, INC. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
259 ballot items at 27 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Roundhill GLP-1 & Weight Loss ETF (OZEM) voted at 27 shareholder meetings of 26 companies, on 259 ballot items in all. Where management made a recommendation, the fund followed it on 94.2% of the items and voted against it 7 times. Its most frequent area of disagreement was corporate governance (4 of its votes against management). It voted on 7 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.